angiotensin ii, des-phe(8)- has been researched along with Sclerosis, Systemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bergler-Czop, B; Brzezińska-Wcisło, L; Kopeć-Mędrek, M; Kotyla, P; Kucharz, E; Miziołek, B; Sieńczyk, M; Widuchowska, M | 1 |
| Chappell, MC | 1 |
| Bartoli, F; Brosnihan, KB; Cerinic, MM; Cinelli, M; Ferrario, CM; Fiori, G; Generini, S; Guiducci, S; Livi, R; Perfetto, F; Pignone, A; Rogai, V; Rosso, AD; Tempestini, A | 1 |
3 other study(ies) available for angiotensin ii, des-phe(8)- and Sclerosis, Systemic
| Article | Year |
|---|---|
Significance of the angiotensin I/angiotensin II/angiotensin-(1-7) axis in the pathogenesis of systemic sclerosis.
Topics: Adult; Aged; Angiotensin I; Angiotensin II; Female; Humans; Male; Middle Aged; Peptide Fragments; Scleroderma, Systemic; Young Adult | 2020 |
Angiotensin-converting enzyme 2 autoantibodies: further evidence for a role of the renin-angiotensin system in inflammation.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Autoantibodies; Humans; Hypertension; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Scleroderma, Systemic | 2010 |
Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control.
Topics: Angiotensin I; Angiotensin II; Antihypertensive Agents; Epoprostenol; Female; Humans; Male; Middle Aged; Neprilysin; Nitric Oxide; Peptide Fragments; Peptidyl-Dipeptidase A; Scleroderma, Systemic; Vasoconstrictor Agents | 2007 |